CEO Thomas K. Equels, J.D. COO Peter W. Rodino III, J.D. CFO Ellen Lintal
CEO & Executive Director
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
